RenovoRx Regains Nasdaq Minimum Bid Price Compliance After 10 Business Days Above $1.00
RenovoRx said Nasdaq confirmed on August 20, 2026 that it has regained compliance with the Nasdaq minimum bid price requirement, and Nasdaq considers the matter closed. The closing bid price was at or above $1.00 per share for the ten consecutive business days from August 6 through August 19, 2026. The filing removes a listing deficiency that had been pending since December 31, 2025, but it reports no financial results or business changes.
Key points
- Nasdaq notified RenovoRx on December 31, 2025 that its stock had closed below $1.00 for 30 consecutive business days.
- Nasdaq confirmed on August 20, 2026 that the closing bid price was $1.00 or greater for ten consecutive business days, August 6 through August 19, 2026.
- Nasdaq considers the minimum bid price matter closed; the filing reports no financial results or other business developments.
The filing
Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 20, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.